Literature DB >> 350368

Tourette's syndrome: a treatable tic.

T J Murray.   

Abstract

Tourette's syndrome, or Gilles de la Tourette's disease, is a disorder characterized by involuntary tic-like muscular movements, compulsive behaviour and involuntary vocalization of sounds, words or profanities. It begins in childhood and may persist for life, with a varied pattern and course. Recent studies indicate an organic basis for the disorder, and an abnormality of dopamine or purine metabolism has been suggested. The treatment of choice is haloperidol administration; most patients do well with low or moderate doses for long periods. Because these patients are often mistakenly regarded as anxious, psychoneurotic or hysterical, correct diagnosis is important if they are to be treated appropriately and regarded properly in the home, school and society.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 350368      PMCID: PMC1818383     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  15 in total

1.  Compulsory shouting (Benedek's "klazomania") associated with oculogyric spasms in chronic epidemic encephalitis.

Authors:  G Wohlfart; D H Ingvar; A M Hellberg
Journal:  Acta Psychiatr Scand       Date:  1961       Impact factor: 6.392

2.  Purine phosphoribosyltransferase in gilles de la Tourette syndrome.

Authors:  M H Van Woert; L C Yip; M E Balis
Journal:  N Engl J Med       Date:  1977-01-27       Impact factor: 91.245

3.  The role of brain dopamine in behavioral regulation and the actions of psychotropic drugs.

Authors:  S H Snyder; K M Taylor; J T Coyle; J L Meyerhoff
Journal:  Am J Psychiatry       Date:  1970-08       Impact factor: 18.112

4.  The serum urate level reflects degree of stress.

Authors:  C C Pfeiffer; V Iliev; R E Nichols; A A Sugerman
Journal:  J Clin Pharmacol J New Drugs       Date:  1969 Nov-Dec

Review 5.  Gilles de la Tourette's syndrome. A report on four cases and a review of published case reports.

Authors:  S J Fernando
Journal:  Br J Psychiatry       Date:  1967-06       Impact factor: 9.319

6.  Neurological features of Gilles de la Tourette's syndrome.

Authors:  R D Sweet; G E Solomon; H Wayne; E Shapiro; A K Shapiro
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-02       Impact factor: 10.154

7.  Dopaminergic function in Gilles de la Tourette's syndrome, Sydenham's chorea and torsion dystonia.

Authors:  S Lal; J Allen; P Etienne; T L Sourkes; P Humphreys
Journal:  Clin Neurol Neurosurg       Date:  1976       Impact factor: 1.876

8.  Seven cases of Gilles de la tourette's syndrome: partial relief with clonazepam: a pilot study.

Authors:  M Gonce; A Barbeau
Journal:  Can J Neurol Sci       Date:  1977-11       Impact factor: 2.104

9.  The use of methylphenidate and imipramine in Gilles de la Tourette's disease in children.

Authors:  I Fras; J Karlavage
Journal:  Am J Psychiatry       Date:  1977-02       Impact factor: 18.112

10.  Gilles de la Tourette's syndrome: clinical, genetic, psychologic, and biochemical aspects in 21 selected families.

Authors:  R Eldridge; R Sweet; R Lake; M Ziegler; A K Shapiro
Journal:  Neurology       Date:  1977-02       Impact factor: 9.910

View more
  3 in total

1.  Tourette syndrome.

Authors:  T J Murray
Journal:  Can Fam Physician       Date:  1982-02       Impact factor: 3.275

2.  Tourette's syndrome in a black woman with associated triple X and 9p mosaicism.

Authors:  D N Singh; G L Howe; H W Jordan; S Hara
Journal:  J Natl Med Assoc       Date:  1982-07       Impact factor: 1.798

3.  Tourette's syndrome: update.

Authors:  R D Freeman; J E Connolly; P A Baird
Journal:  Can Med Assoc J       Date:  1984-06-15       Impact factor: 8.262

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.